HIMS

Hims & Hers Health, Inc.

There isn't enough reported data to score HIMS yet.

LEGN

Legend Biotech Corporation

60
Fundamentals68/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential38/ 100

LEGN lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

HIMS Fundamentals

MetricStatus
Strong
Weak
Stable
Strong

HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.

LEGN Fundamentals

MetricStatus
Healthy
Stable
Weak
Unavailable

LEGN's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.

HIMS PE Valuation

HIMS has no meaningful PE right now: it lost money over the past year.

LEGN PE Valuation

LEGN has no meaningful PE right now: it lost money over the past year.

HIMS Forward outlook

MetricOutlook
--
Turning to a loss
Strong growth
Stable
Limited
Low

Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.

LEGN Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Strongly improving
Limited
Low

LEGN has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.

HIMS Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $19.73 on Nov 12.

There is not enough scenario data to compare HIMS and LEGN's risk to reward.

LEGN Risk to reward

ScenarioChangePrice
Upside+62%$30.11
Downside-38%$11.51

Calculated from the latest close: $18.54 on Nov 12.

There is not enough scenario data to compare HIMS and LEGN's risk to reward.

HIMS Earnings Per Share

Q4 2023: $-0.11Q1 2024: $-0.01Q2 2024: $0.08Q3 2024: $0.44Q4 2024: $0.53Q1 2025: $0.68Q2 2025: $0.79Q3 2025: $0.53Q4 2025: $0.51Q1 2026: $-0.09Q2 2026: $-0.63Q3 2026: $-0.83
Q4 2023: $-0.11Q1 2024: $-0.01Q2 2024: $0.08Q3 2024: $0.44Q4 2024: $0.53Q1 2025: $0.68Q2 2025: $0.79Q3 2025: $0.53Q4 2025: $0.51Q1 2026: $-0.09Q2 2026: $-0.63Q3 2026: $-0.83
QuarterTTM EPSYoY
Q3 2026-$0.83-257%
Q2 2026-$0.63-180%
Q1 2026-$0.09-113%
Q4 2025$0.51-3.8%
Q3 2025$0.53+20%
Q2 2025$0.79+888%
Q1 2025$0.68+$0.69
Q4 2024$0.53+$0.64

HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.

LEGN Earnings Per Share

Q3 2023: $-3.01Q4 2023: $-2.96Q1 2024: $-2.44Q2 2024: $-1.40Q3 2024: $-1.74Q4 2024: $-0.87Q1 2025: $-0.98Q2 2025: $-1.22Q3 2025: $-0.65Q4 2025: $-0.89Q1 2026: $-0.92Q2 2026: $-0.40
Q3 2023: $-3.01Q4 2023: $-2.96Q1 2024: $-2.44Q2 2024: $-1.40Q3 2024: $-1.74Q4 2024: $-0.87Q1 2025: $-0.98Q2 2025: $-1.22Q3 2025: $-0.65Q4 2025: $-0.89Q1 2026: $-0.92Q2 2026: $-0.40
QuarterTTM EPSYoY
Q2 2026-$0.40+$0.82
Q1 2026-$0.92+$0.06
Q4 2025-$0.89-$0.02
Q3 2025-$0.65+$1.09
Q2 2025-$1.22+$0.18
Q1 2025-$0.98+$1.46
Q4 2024-$0.87+$2.09
Q3 2024-$1.74+$1.27

LEGN has the edge over HIMS on earnings, with more consistent year-over-year improvement.

HIMS Quarterly Revenue

Q4 2023: $247MQ1 2024: $278MQ2 2024: $316MQ3 2024: $402MQ4 2024: $481MQ1 2025: $586MQ2 2025: $545MQ3 2025: $599MQ4 2025: $618MQ1 2026: $608MQ2 2026: $753MQ3 2026: $890M
Q4 2023: $247MQ1 2024: $278MQ2 2024: $316MQ3 2024: $402MQ4 2024: $481MQ1 2025: $586MQ2 2025: $545MQ3 2025: $599MQ4 2025: $618MQ1 2026: $608MQ2 2026: $753MQ3 2026: $890M
QuarterRevenueYoY
Q3 2026$890.4M+49%
Q2 2026$753.2M+38%
Q1 2026$608.1M+3.8%
Q4 2025$617.8M+28%
Q3 2025$599M+49%
Q2 2025$544.8M+73%
Q1 2025$586M+111%
Q4 2024$481.1M+95%

HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.

LEGN Quarterly Revenue

Q3 2023: $96MQ4 2023: $79MQ1 2024: $94MQ2 2024: $187MQ3 2024: $160MQ4 2024: $187MQ1 2025: $195MQ2 2025: $255MQ3 2025: $272MQ4 2025: $306MQ1 2026: $305MQ2 2026: $388M
Q3 2023: $96MQ4 2023: $79MQ1 2024: $94MQ2 2024: $187MQ3 2024: $160MQ4 2024: $187MQ1 2025: $195MQ2 2025: $255MQ3 2025: $272MQ4 2025: $306MQ1 2026: $305MQ2 2026: $388M
QuarterRevenueYoY
Q2 2026$387.5M+52%
Q1 2026$305.1M+56%
Q4 2025$306.4M+64%
Q3 2025$272.3M+70%
Q2 2025$255.1M+37%
Q1 2025$195.1M+108%
Q4 2024$186.5M+135%
Q3 2024$160.2M+67%

LEGN has the edge over HIMS on sales, with stronger typical year-over-year growth.

HIMS Free Cash Flow

Q4 2023: $22MQ1 2024: $26MQ2 2024: $54MQ3 2024: $85MQ4 2024: --Q1 2025: $50MQ2 2025: −$70MQ3 2025: $79MQ4 2025: −$3MQ1 2026: $53MQ2 2026: −$68MQ3 2026: $26M
Q4 2023: $22MQ1 2024: $26MQ2 2024: $54MQ3 2024: $85MQ4 2024: --Q1 2025: $50MQ2 2025: −$70MQ3 2025: $79MQ4 2025: −$3MQ1 2026: $53MQ2 2026: −$68MQ3 2026: $26M
QuarterFree cash flowYoY
Q3 2026$26M-67%
Q2 2026-$68.2M+$1.3M
Q1 2026$53.1M+5.9%
Q3 2025$79.3M-7%
Q2 2025-$69.5M-230%
Q1 2025$50.1M+94%
Q3 2024$85.3M+238%
Q2 2024$53.6M+219%

HIMS has the edge over LEGN on cash generation, producing positive trailing cash flow while its opponent burns cash.

LEGN Free Cash Flow

Q3 2023: −$66MQ4 2023: −$102MQ1 2024: $9MQ2 2024: −$5MQ3 2024: −$78MQ4 2024: −$84MQ1 2025: −$106MQ2 2025: −$22MQ3 2025: $24MQ4 2025: −$127MQ1 2026: −$111MQ2 2026: −$41M
Q3 2023: −$66MQ4 2023: −$102MQ1 2024: $9MQ2 2024: −$5MQ3 2024: −$78MQ4 2024: −$84MQ1 2025: −$106MQ2 2025: −$22MQ3 2025: $24MQ4 2025: −$127MQ1 2026: −$111MQ2 2026: −$41M
QuarterFree cash flowYoY
Q2 2026-$41.5M-$19.2M
Q1 2026-$111.3M-$5.6M
Q4 2025-$126.6M-$42.1M
Q3 2025$23.8M+$101.7M
Q2 2025-$22.3M-$17.2M
Q1 2025-$105.8M-1240%
Q4 2024-$84.5M+$18M
Q3 2024-$77.9M-$11.6M

LEGN has burned cash in almost every quarter: −$256M over the past year, against −$290M the year before.

HIMS Total Shares

Q4 2023: 209MQ1 2024: 229MQ2 2024: 235MQ3 2024: 235MQ4 2024: 237MQ1 2025: 247MQ2 2025: 257MQ3 2025: 249MQ4 2025: 258MQ1 2026: 228MQ2 2026: 232MQ3 2026: 234M
Q4 2023: 209MQ1 2024: 229MQ2 2024: 235MQ3 2024: 235MQ4 2024: 237MQ1 2025: 247MQ2 2025: 257MQ3 2025: 249MQ4 2025: 258MQ1 2026: 228MQ2 2026: 232MQ3 2026: 234M
PeriodChange %Net change
Quarterly+0.9%+2.1M shares
1 year-6%-14.9M shares
3 years+11%+23.7M shares
5 years+17%+33.8M shares

HIMS has 234M diluted shares, down 6% from a year ago.

LEGN Total Shares

Q3 2023: 182MQ4 2023: 182MQ1 2024: 364MQ2 2024: 183MQ3 2024: 183MQ4 2024: 366MQ1 2025: 368MQ2 2025: 368MQ3 2025: 369MQ4 2025: 185MQ1 2026: 185MQ2 2026: 194M
Q3 2023: 182MQ4 2023: 182MQ1 2024: 364MQ2 2024: 183MQ3 2024: 183MQ4 2024: 366MQ1 2025: 368MQ2 2025: 368MQ3 2025: 369MQ4 2025: 185MQ1 2026: 185MQ2 2026: 194M
PeriodChange %Net change
Quarterly+4.9%+9.1M shares
1 year-47%-174M shares
3 years+11%+18.5M shares
5 years+40%+55.3M shares
Available history+93%+93.6M shares

LEGN has the edge over HIMS on shareholder dilution, with a more favorable share count trend.

HIMS Net Leverage

Q1 2024: -49.8xQ2 2024: -5.5xQ3 2024: -2.9xQ4 2024: -2.8xQ1 2025: -2.1xQ2 2025: -7.3xQ3 2025: -2.2xQ4 2025: -1.4xQ1 2026: -5.9x
Q1 2024: -49.8xQ2 2024: -5.5xQ3 2024: -2.9xQ4 2024: -2.8xQ1 2025: -2.1xQ2 2025: -7.3xQ3 2025: -2.2xQ4 2025: -1.4xQ1 2026: -5.9x
QuarterNet LeverageStatus
Q1 2026-5.9xNet Cash
Q4 2025-1.4xNet Cash
Q3 2025-2.2xNet Cash
Q2 2025-7.3xNet Cash
Q1 2025-2.1xNet Cash
Q4 2024-2.8xNet Cash
Q3 2024-2.9xNet Cash
Q2 2024-5.5xNet Cash

HIMS has more cash than debt.

LEGN Net Leverage

LEGN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

HIMS Weekly Momentum

MetricValueStatus
RSI36.0Neutral
Stochastic23.0Neutral

HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).

LEGN Weekly Momentum

MetricValueStatus
RSI43.8Neutral
Stochastic63.0Neutral

LEGN's weekly RSI is 44 (neutral) and its Stochastic is 63 (neutral).

HIMS PE vs Healthcare Sector

MetricHIMSSector medianRelative
PEN/A26x—

HIMS has no meaningful PE right now: it lost money over the past year.

LEGN PE vs Healthcare Sector

LEGN has no meaningful PE right now: it lost money over the past year.

HIMS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$27.328% below
20 week MA$29.232% below
50 week MA$27.729% below
100 week MA$35.945% below
200 week MA$24.419% below

HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.

LEGN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$19.75.9% below
20 week MA$20.911% below
50 week MA$22.116% below
100 week MA$28.234% below
200 week MA$42.356% below

LEGN is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.

HIMS Yearly ROI

YearStart priceEnd priceROI
2020$9.89$15.0+51%
2021$15.0$6.65-56%
2022$6.65$6.43-3.3%
2023$6.43$8.90+38%
2024$8.90$26.6+198%
2025$26.6$34.3+29%
2026 YTD$34.3$19.7-42%

HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.

LEGN Yearly ROI

YearStart priceEnd priceROI
2020$37.0$29.5-20%
2021$29.5$48.7+65%
2022$48.7$49.8+2.3%
2023$49.8$60.2+21%
2024$60.2$32.5-46%
2025$32.5$22.5-31%
2026 YTD$22.5$18.5-18%

LEGN has the edge over HIMS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key